← Evidence map

ArticleThe Lancet. Global health2022

Fluvoxamine for the treatment of COVID-19 - Author's reply.

Gilmar Reis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35180413